Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1978 Sep;27(3):648–658. doi: 10.1128/jvi.27.3.648-658.1978

Specificity of interferon action in protein synthesis.

P M Yau, T Godefroy-Colburn, C H Birge, T V Ramabhadran, R E Thach
PMCID: PMC525853  PMID: 212587

Abstract

Inhibitors of elongation steps in protein synthesis such as cycloheximide and anisomycin mimic interferon treatment in that they specifically inhibit the synthesis of certain viral proteins. These specific effects are seen only at very low concentrations of the antibiotics, under conditions where host cellular protein synthesis, as well as cell viability, are not severely reduced. A qualitatively as well as quantitatively close correlation between the effects of the two types of agents has been established for encephalomyocarditis virus, vesicular stomatitis virus and murine leukemia virus protein synthesis. It is concluded that one of the primary mechanisms of interferon action may be a nonspecific retardation of one or more elongation steps, and that this may be sufficient to account for its effects on the replication of certain viruses such as encephalomyocarditis and vesicular stomatitis viruses.

Full text

PDF
648

Images in this article

651Image
on p.651
652Image
on p.652
654Image
on p.654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. A. Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol. 1971 Apr;21(4):723–725. doi: 10.1128/am.21.4.723-725.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Billiau A., Edy V. G., Sobis H., de Somer P. Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release. Int J Cancer. 1974 Sep 15;14(3):335–340. doi: 10.1002/ijc.2910140306. [DOI] [PubMed] [Google Scholar]
  3. Colby C., Penhoet E. E., Samuel C. E. A comparison of transfer RNA from untreated and interferon-treated murine cells. Virology. 1976 Oct 1;74(1):262–264. doi: 10.1016/0042-6822(76)90153-7. [DOI] [PubMed] [Google Scholar]
  4. Content J., Lebleu B., Nudel U., Zilberstein A., Berissi H., Revel M. Blocks in elongation and initiation of protein synthesis induced by interferon treatment in mouse L cells. Eur J Biochem. 1975 May;54(1):1–10. doi: 10.1111/j.1432-1033.1975.tb04106.x. [DOI] [PubMed] [Google Scholar]
  5. Content J., Lebleu B., Zilberstein A., Berissi H., Revel M. Mechanism of the interferon-induced block of mRNA translation in mouse L cells: reversal of the block by transfer RNA. FEBS Lett. 1974 Apr 15;41(1):125–130. doi: 10.1016/0014-5793(74)80970-1. [DOI] [PubMed] [Google Scholar]
  6. Friedman R. M., Chang E. H., Ramseur J. M., Myers M. W. Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. J Virol. 1975 Sep;16(3):569–574. doi: 10.1128/jvi.16.3.569-574.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Golini F., Thach S. S., Birge C. H., Safer B., Merrick W. C., Thach R. E. Competition between cellular and viral mRNAs in vitro is regulated by a messenger discriminatory initiation factor. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3040–3044. doi: 10.1073/pnas.73.9.3040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jen G., Birge C. H., Thach R. E. Comparison of initiation rates of encephalomyocarditis virus and host protein synthesis in infected cells. J Virol. 1978 Sep;27(3):640–647. doi: 10.1128/jvi.27.3.640-647.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jimenez A., Sanchez L., Vazquez D. Simultaneous ribosomal resistance to trichodermin and anisomycin in Saccharomyces cerevisiae mutants. Biochim Biophys Acta. 1975 Apr 2;383(4):427–434. doi: 10.1016/0005-2787(75)90312-3. [DOI] [PubMed] [Google Scholar]
  10. Kerr I. M., Friedman R. M., Brown R. E., Ball L. A., Brown J. C. Inhibition of Protein Synthesis in Cell-Free Systems from Interferon-Treated, Infected Cells: Further Characterization and Effect of Formylmethionyl-tRNA(F). J Virol. 1974 Jan;13(1):9–21. doi: 10.1128/jvi.13.1.9-21.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kerr I. M., Martin E. M. Simple method for the isolation of encephalomyocarditis virus ribonucleic acid. J Virol. 1972 Mar;9(3):559–561. doi: 10.1128/jvi.9.3.559-561.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Knight E., Jr Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature. 1976 Jul 22;262(5566):302–303. doi: 10.1038/262302a0. [DOI] [PubMed] [Google Scholar]
  13. Knight E., Jr Heterogeneity of purified mouse interferons. J Biol Chem. 1975 Jun 10;250(11):4139–4144. [PubMed] [Google Scholar]
  14. Laskey R. A., Mills A. D. Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975 Aug 15;56(2):335–341. doi: 10.1111/j.1432-1033.1975.tb02238.x. [DOI] [PubMed] [Google Scholar]
  15. Lawrence C., Thach R. E. Encephalomyocarditis virus infection of mouse plasmacytoma cells. I. Inhibition of cellular protein synthesis. J Virol. 1974 Sep;14(3):598–610. doi: 10.1128/jvi.14.3.598-610.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lodish H. F. Alpha and beta globin messenger ribonucleic acid. Different amounts and rates of initiation of translation. J Biol Chem. 1971 Dec 10;246(23):7131–7138. [PubMed] [Google Scholar]
  17. Lodish H. F. Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature. 1974 Oct 4;251(5474):385–388. doi: 10.1038/251385a0. [DOI] [PubMed] [Google Scholar]
  18. MARTIN E. M., MALEC J., SVED S., WORK T. S. Studies on protein and nucleic acid metabolism in virus-infected mammalian cells. 1. Encephalomyocarditis virus in Krebs II mouse-ascites-tumour cells. Biochem J. 1961 Sep;80:585–597. doi: 10.1042/bj0800585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Metz D. H., Esteban M., Danielescu G. The effect of interferon on the formation of virus polyribosomes in L cells infected with vaccinia virus. J Gen Virol. 1975 May;27(2):197–209. doi: 10.1099/0022-1317-27-2-197. [DOI] [PubMed] [Google Scholar]
  20. Nuss D. L., Koch G. Differential inhibition of vesicular stomatitis virus polypeptide synthesis by hypertonic initiation block. J Virol. 1975 Jan;17(1):283–286. doi: 10.1128/jvi.17.1.283-286.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nuss D. L., Oppermann H., Koch G. Selective blockage of initiation of host protein synthesis in RNA-virus-infected cells. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1258–1262. doi: 10.1073/pnas.72.4.1258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Obrig T. G., Irvin J. D., Hardesty B. The effect of an antiviral peptide on the ribosomal reactions of the peptide elongation enzymes, EF-I and EF-II. Arch Biochem Biophys. 1973 Apr;155(2):278–289. doi: 10.1016/0003-9861(73)90116-1. [DOI] [PubMed] [Google Scholar]
  23. Pitha P. M., Rowe W. P., Oxman M. N. Effect of interferon on exogenous, endogenous, and chroniv murine leukemia virus infection. Virology. 1976 Apr;70(2):324–338. doi: 10.1016/0042-6822(76)90275-0. [DOI] [PubMed] [Google Scholar]
  24. Robertson D. L., Yau P., Dobbertin D. C., Sweeney T. K., Thach S. S., Brendler T., Thach R. E. Relationships between intracisternal type A and extracellular oncornavirus-like particles produced in murine MOPC-460 myeloma cells. J Virol. 1976 Apr;18(1):344–355. doi: 10.1128/jvi.18.1.344-355.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Samuel C. E. Mechanism of interferon action. Studies on the mechanism of interferon-mediated inhibition of reovirus messenger RNA translation in cell-free protein synthesis systems from mouse ascites tumor cells. Virology. 1976 Nov;75(1):166–176. doi: 10.1016/0042-6822(76)90015-5. [DOI] [PubMed] [Google Scholar]
  26. Sen G. C., Gupta S. L., Brown G. E., Lebleu B., Rebello M. A., Lengyel P. Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J Virol. 1975 Jan;17(1):191–203. doi: 10.1128/jvi.17.1.191-203.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stanners C. P., Francoeur A. M., Lam T. Analysis of VSV mutant with attenuated cytopathogenicity: mutation in viral function, P, for inhibition of protein synthesis. Cell. 1977 Jun;11(2):273–281. doi: 10.1016/0092-8674(77)90044-7. [DOI] [PubMed] [Google Scholar]
  28. Stewart W. E., 2nd, Gresser I., Tovey M. G., Bandu M., Le Goff S. Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature. 1976 Jul 22;262(5566):300–302. doi: 10.1038/262300a0. [DOI] [PubMed] [Google Scholar]
  29. Wiebe M. E., Joklik T. W. The mechanism of inhibition of reovirus replication by interferon. Virology. 1975 Jul;66(1):229–240. doi: 10.1016/0042-6822(75)90193-2. [DOI] [PubMed] [Google Scholar]
  30. Wu A. M., Schultz A., Gallo R. C. Synthesis of type C virus particles from murine-cultured cells induced by iododeoxyuridine. V. Effect of interferon and its interaction with dexamethasone. J Virol. 1976 Jul;19(1):108–117. doi: 10.1128/jvi.19.1.108-117.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yakobson E., Prives C., Hartman J. R., Winocour E., Revel M. Inhibition of viral protein synthesis in monkey cells treated with interferon late in simian virus 40 lytic cycle. Cell. 1977 Sep;12(1):73–81. doi: 10.1016/0092-8674(77)90186-6. [DOI] [PubMed] [Google Scholar]
  32. Zilberstein A., Dudock B., Berissi H., Revel M. Control of messenger RNA translation by minor species of leucyl-transfer RNA in extracts from interferon-treated L cells. J Mol Biol. 1976 Nov;108(1):43–54. doi: 10.1016/s0022-2836(76)80093-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES